These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

122 related items for PubMed ID: 4578947

  • 1. Site of inactivation of melanocyte-stimulating hormone-release-inhibiting hormone by human plasma.
    Nair RM, Redding TW, Kastin AJ, Schally AV.
    Biochem Pharmacol; 1973 Aug 01; 22(15):1915-9. PubMed ID: 4578947
    [No Abstract] [Full Text] [Related]

  • 2. Isolation and structure of hypothalamic MSH release-inhibition hormone.
    Nair RM, Kastin AJ, Schally AV.
    Biochem Biophys Res Commun; 1971 Jun 18; 43(6):1376-81. PubMed ID: 4398196
    [No Abstract] [Full Text] [Related]

  • 3. Production of MSH-release-inhibiting hormone by a particulate preparation of hypothalami: mechanisms of oxytocin inactivation.
    Walter R, Griffiths EC, Hooper KC.
    Brain Res; 1973 Oct 12; 60(2):449-57. PubMed ID: 4587290
    [No Abstract] [Full Text] [Related]

  • 4. Isolation and structure of another hypothalamic peptide possessing MSH-release-inhibiting activity.
    Nair RM, Kastin AJ, Schally AV.
    Biochem Biophys Res Commun; 1972 Jun 28; 47(6):1420-5. PubMed ID: 5040241
    [No Abstract] [Full Text] [Related]

  • 5. Estrogen influence on the hypothalamic enzymes involved in the formation of melanocyte-stimulating hormone release-inhibiting factor (MSH-R-IF).
    Celis ME, Taleisnik S.
    Proc Soc Exp Biol Med; 1974 Jan 28; 145(1):142-4. PubMed ID: 4591390
    [No Abstract] [Full Text] [Related]

  • 6. MSH-release inhibiting factors: recent studies.
    Kastin AJ, Plotnikoff NP, Viosca S, Anderson MS, Schally AV.
    Yale J Biol Med; 1973 Dec 28; 46(5):617-22. PubMed ID: 4591788
    [No Abstract] [Full Text] [Related]

  • 7. 13C nuclear magnetic resonance studies of the conformation of the X-pro bond in the oligopeptide hormones, thyrotropin-releasing hormone, luteinizing hormone-releasing factor, angiotensin and melanocyte-stimulating hormone release-inhibiting factor.
    Deslauriers R, Walter R, Smith IC.
    Biochem Biophys Res Commun; 1973 Jul 02; 53(1):244-50. PubMed ID: 4354931
    [No Abstract] [Full Text] [Related]

  • 8. Studies on the inhibition of oxotremorine induced tremor by a melanocyte-stimulating hormone release-inhibiting factor, thyrotropin releasing hormone and related peptides.
    Castensson S, Sievertsson H, Lindeke B, Sum CY.
    FEBS Lett; 1974 Aug 15; 44(1):101-5. PubMed ID: 4212370
    [No Abstract] [Full Text] [Related]

  • 9. Structure-activity studies of MSH-release-inhibiting hormone.
    Celis ME, Hase S, Walter R.
    FEBS Lett; 1972 Nov 01; 27(2):327-30. PubMed ID: 4352026
    [No Abstract] [Full Text] [Related]

  • 10. The present concept of the nature of hypothalamic hormones stimulating and inhibiting the release of pituitary hormones.
    Schally AV, Kastin AJ.
    Triangle; 1969 Nov 01; 9(1):19-25. PubMed ID: 4980829
    [No Abstract] [Full Text] [Related]

  • 11. Hypothalamic and cerebral cortical inhibitors of a melanocyte-stimulating substance secreted by the pars distalis of the frog pituitary gland.
    Bercu BB, Brinkley HJ.
    Experientia; 1969 Aug 15; 25(8):879-80. PubMed ID: 4900011
    [No Abstract] [Full Text] [Related]

  • 12. The disappearance, excretion, and metabolism of tritiated prolyl-leucyl-glycinamide in man.
    Redding TW, Kastin AJ, Gonzalez-Barcena D, Coy DH, Hirotsu Y, Ruelas J, Schally AV.
    Neuroendocrinology; 1974 Aug 15; 16(2):119-26. PubMed ID: 4610443
    [No Abstract] [Full Text] [Related]

  • 13. Chemistry of releasing hormones.
    Sandow J.
    J Endocrinol; 1973 Aug 15; 58(2):32-3. PubMed ID: 4199267
    [No Abstract] [Full Text] [Related]

  • 14. Carbon-13 NMR studies of peptide hormones and their components.
    Smith IC, Deslauriers R, Saitô H, Walter R, Garrigou-Lagrange C, McGregor H, Sarantakis D.
    Ann N Y Acad Sci; 1973 Dec 31; 222():597-627. PubMed ID: 4361873
    [No Abstract] [Full Text] [Related]

  • 15. Formation of a melanocyte-stimulating hormone-release inhibiting factor by hypothalamic extracts from rats.
    Celis ME, Taleisnik S.
    Int J Neurosci; 1971 Apr 31; 1(4):223-30. PubMed ID: 4949884
    [No Abstract] [Full Text] [Related]

  • 16. Inactivation of melanocyte-stimulating hormone release-inhibiting factor by a manganese-stimulated bovine brain aminopeptidase.
    Simmons WH, Brecher AS.
    J Biol Chem; 1973 Aug 25; 248(16):5780-4. PubMed ID: 4353274
    [No Abstract] [Full Text] [Related]

  • 17. Intramolecular motion in peptide determined by 13C NMR: a spin-lattice relaxation time-study on MSH-release-inhibiting factor.
    Deslauriers R, Walter R, Smith IC.
    FEBS Lett; 1973 Nov 15; 37(1):27-32. PubMed ID: 4585031
    [No Abstract] [Full Text] [Related]

  • 18. Effect of melanocyte-stimulating hormone-release inhibiting factor (MIF) in Parkinson's syndrom.
    Fischer PA, Schneider E, Jacobi P, Maxion H.
    Eur Neurol; 1974 Nov 15; 12(5-6):360-8. PubMed ID: 4614981
    [No Abstract] [Full Text] [Related]

  • 19. Hypothalamic regulatory hormones: a review.
    Besser GM, Mortimer CH.
    J Clin Pathol; 1974 Mar 15; 27(3):173-84. PubMed ID: 4208913
    [No Abstract] [Full Text] [Related]

  • 20. Biosynthesis in vitro of the luteinizing releasing hormone by hypothalamic tissue.
    Johansson NG, Hooper F, Sievertsson H, Currie BL, Folkers K, Bowers CY.
    Biochem Biophys Res Commun; 1972 Nov 01; 49(3):656-60. PubMed ID: 4565124
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.